<DOC>
	<DOCNO>NCT02602535</DOCNO>
	<brief_summary>The central aim study test efficacy Mindfulness-Oriented Recovery Enhancement ( MORE ) , intervention design disrupt risk chain lead chronic pain prescription opioid misuse addiction . The investigator plan conduct full scale clinical trial determine whether MORE ( relative support group control condition ) reduce symptom chronic pain opioid misuse among patient receive pain management primary care via long-term opioid analgesic therapy .</brief_summary>
	<brief_title>Mindfulness-Oriented Recovery Enhancement For Chronic Pain Prescription Opioid Misuse Primary Care</brief_title>
	<detailed_description />
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<criteria>Age 1860+ Current back pain diagnosis determine ICD9 code claim data ( include limit ICD9 diagnose 724.x , 847.x ) current chronic pain diagnosis determine physician assessment ( include limit ICD9 diagnose 338.0 , 338.21 , 338.22 , 338.28 , 338.29 , 338.4 ) Current use prescription opioid agonist mixed agonistantagonist analgesic &gt; 90 day Willingness participate study intervention assessment Prior experience MindfulnessBased Stress Reduction , MindfulnessBased Cognitive Therapy , MindfulnessBased Relapse Prevention Active suicidality , schizophrenia , psychotic disorder , and/or substance dependence ( opioid dependence ) Presence clinically unstable systemic illness judge interfere treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>